AddLife AB (publ) (LON:0REZ)
180.30
+0.32 (0.18%)
At close: Oct 20, 2025
AddLife AB Market Cap
AddLife AB has a market cap or net worth of 2.02 billion as of October 24, 2025. Its market cap has increased by 41.33% in one year.
Market Cap
2.02B
Enterprise Value
2.40B
Revenue
831.12M
Ranking
n/a
PE Ratio
64.84
Stock Price
180.30
Market Cap Chart
Since March 16, 2016, AddLife AB's market cap has increased from 184.67M to 2.02B, an increase of 992.26%. That is a compound annual growth rate of 28.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 24, 2025 | 2.02B | 66.62% |
| Dec 30, 2024 | 1.21B | 16.66% |
| Dec 29, 2023 | 1.04B | -1.47% |
| Dec 30, 2022 | 1.05B | -72.35% |
| Dec 30, 2021 | 3.81B | 162.61% |
| Dec 30, 2020 | 1.45B | 119.05% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 194.46B |
| GSK plc | 66.45B |
| Haleon | 31.57B |
| Smith & Nephew | 11.83B |
| ConvaTec Group | 4.95B |
| Hikma Pharmaceuticals | 3.94B |
| HUTCHMED (China) | 1.96B |
| Genus | 1.74B |